SCHEMBL2402745

SCHEMBL2402745

[CH2]CCCC(=O)NCCCCNC(=N)N

nearest known ligand 0.46

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
ALOX15 P16050 1/20 0.46
SMN1; SMN2 Q16637 3/20 0.46
MEN1 O00255 2/20 0.46
KMT2A Q03164 2/20 0.46
CYP1A2 P05177 1/20 0.46
CASP2 P42575 1/20 0.40
TSHR P16473 3/20 0.39
TPSAB1 Q15661 1/20 0.38
NAAA Q02083 1/20 0.38
ALDH1A1 P00352 1/20 0.38
SLC6A5 Q9Y345 2/20 0.36
ITGB3 P05106 2/20 0.36
ITGA2B P08514 2/20 0.36
FAAH O00519 1/20 0.36
LMNA P02545 1/20 0.35
MAPT P10636 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2402217 0.82 TSHR (0.42) SMN1; SMN2MEN1KMT2ACASP2TSHR
SCHEMBL181517 0.82
SCHEMBL12954814 0.81 SLC6A5 (0.46) ALOX15SMN1; SMN2MEN1KMT2ACYP1A2
SCHEMBL12438897 0.81 NAAA (0.46) ALOX15SMN1; SMN2MEN1KMT2ACYP1A2
SCHEMBL9508493 0.81 SLC6A5 (0.53) SMN1; SMN2MEN1KMT2ACASP2TSHR
SCHEMBL13399998 0.81 ALOX15 (0.44) ALOX15SMN1; SMN2MEN1KMT2ACYP1A2
SCHEMBL3986924 0.80 PRMT1 (0.55) SMN1; SMN2MEN1KMT2ACYP1A2CASP2
SCHEMBL27112953 0.80 CASP2 (0.61) CASP2NAAASLC6A5FAAH
SCHEMBL8770877 0.80 PRMT1 (0.55) SMN1; SMN2MEN1KMT2ACYP1A2CASP2
SCHEMBL26870168 0.80 PRMT1 (0.55) SMN1; SMN2MEN1KMT2ACYP1A2CASP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-105017481-B Cross-linked polyvinylamine, polyallylamine as bile acid sequestrant and aziridine 瑞立普萨公司 2018-10-02 CN claimed
CN-107266681-A Amine polymer as bile acid sequestrant 瑞立普萨公司 2017-10-20 CN claimed
US-20170258825-A1 AMINE POLYMERS FOR USE AS BILE ACID SEQUESTRANTS RELYPSA, INC. 2017-09-14 US claimed
EP-2998329-A2 CROSSLINKED POLYVINYLAMINE, POLYALLYLAMINE, AND POLYETHYLENEIMINE FOR USE AS BILE ACID SEQUESTRANTS Relypsa, Inc. (US) 2016-03-23 EP claimed
US-20160051576-A1 CROSSLINKED POLYVINYLAMINE, POLYALLYLAMINE, AND POLYETHYLENEIMINE FOR USE AS BILE ACID SEQUESTRANTS RELYPSA, INC. (US) 2016-02-25 US claimed
EP-2539389-A1 AMINE POLYMERS FOR USE AS BILE ACID SEQUESTRANTS Relypsa, Inc. (US) 2013-01-02 EP claimed
EP-2539380-A2 CROSSLINKED POLYVRNYLAMINE, POLY ALL YLAMINE, AND POLYETHYLENEIMINE FOR USE AS BILE ACID SEQUESTRANTS Relypsa, Inc. (US) 2013-01-02 EP claimed
WO-2011106542-A2 CROSSLINKED POLYVRNYLAMINE, POLY ALL YLAMINE, AND POLYETHYLENEIMINE FOR USE AS BILE ACID SEQUESTRANTS RELYPSA, INC. (US) 2011-09-01 WO claimed
WO-2011106548-A1 AMINE POLYMERS FOR USE AS BILE ACID SEQUESTRANTS RELYPSA, INC. (US) 2011-09-01 WO claimed
US-10272103-B2 Crosslinked polyvinylamine, polyallylamine, and polyethyleneimine for use as bile acid sequestrants RELYPSA, INC. (US) 2019-04-30 US disclosed
CN-105017481-B Cross-linked polyvinylamine, polyallylamine as bile acid sequestrant and aziridine 瑞立普萨公司 2018-10-02 CN disclosed
EP-2539389-B1 AMINE POLYMERS FOR USE AS BILE ACID SEQUESTRANTS RELYPSA INC (US) 2017-12-20 EP disclosed
CN-107266681-A Amine polymer as bile acid sequestrant 瑞立普萨公司 2017-10-20 CN disclosed
CN-102906159-B Amine polymers as bile acid sequestrants 瑞立普萨公司 2017-09-26 CN disclosed
US-20140356316-A1 AMINE POLYMERS FOR USE AS BILE ACID SEQUESTRANTS RELYPSA, INC. (US) 2014-12-04 US disclosed
US-20130022570-A1 CROSSLINKED POLYVINYLAMINE, POLYALLYLAMINE, AND POLYETHYLENEIMINE FOR USE AS BILE ACID SEQUESTRANTS RELYPSA, INC. (US) 2013-01-24 US disclosed
EP-2539389-A1 AMINE POLYMERS FOR USE AS BILE ACID SEQUESTRANTS Relypsa, Inc. (US) 2013-01-02 EP disclosed
EP-2539380-A2 CROSSLINKED POLYVRNYLAMINE, POLY ALL YLAMINE, AND POLYETHYLENEIMINE FOR USE AS BILE ACID SEQUESTRANTS Relypsa, Inc. (US) 2013-01-02 EP disclosed
WO-2011106548-A1 AMINE POLYMERS FOR USE AS BILE ACID SEQUESTRANTS RELYPSA, INC. (US) 2011-09-01 WO disclosed
WO-2011106542-A2 CROSSLINKED POLYVRNYLAMINE, POLY ALL YLAMINE, AND POLYETHYLENEIMINE FOR USE AS BILE ACID SEQUESTRANTS RELYPSA, INC. (US) 2011-09-01 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160051576-A1 CROSSLINKED POLYVINYLAMINE, POLYALLYLAMINE, AND POLYETHYLENEIMINE FOR USE AS BILE ACID SEQUESTRANTS NR1H4, SLC10A2, GPBAR1 ALOX15 3181/4885SMN1; SMN2 4396/4885MEN1 2378/4885
US-20170258825-A1 AMINE POLYMERS FOR USE AS BILE ACID SEQUESTRANTS NR1H4, SLC10A2, SLC10A1 ALOX15 2085/4885SMN1; SMN2 4281/4885MEN1 1871/4885
US-20140356316-A1 AMINE POLYMERS FOR USE AS BILE ACID SEQUESTRANTS NR1H4, SLC10A2, SLC10A1 ALOX15 2085/4885SMN1; SMN2 4281/4885MEN1 1871/4885
US-10272103-B2 Crosslinked polyvinylamine, polyallylamine, and polyethyleneimine for use as bile acid sequestrants NR1H4, SLC10A2, GPBAR1 ALOX15 3181/4885SMN1; SMN2 4396/4885MEN1 2378/4885
US-20130022570-A1 CROSSLINKED POLYVINYLAMINE, POLYALLYLAMINE, AND POLYETHYLENEIMINE FOR USE AS BILE ACID SEQUESTRANTS NR1H4, SLC10A2, GPBAR1 ALOX15 3181/4885SMN1; SMN2 4396/4885MEN1 2378/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.